ATE113651T1 - Rekonstituierte tumoren, herstellungsverfahren und zusammensetzung für ihre anwendung. - Google Patents

Rekonstituierte tumoren, herstellungsverfahren und zusammensetzung für ihre anwendung.

Info

Publication number
ATE113651T1
ATE113651T1 AT88403371T AT88403371T ATE113651T1 AT E113651 T1 ATE113651 T1 AT E113651T1 AT 88403371 T AT88403371 T AT 88403371T AT 88403371 T AT88403371 T AT 88403371T AT E113651 T1 ATE113651 T1 AT E113651T1
Authority
AT
Austria
Prior art keywords
tumours
composition
application
manufacturing process
reconstituted
Prior art date
Application number
AT88403371T
Other languages
English (en)
Inventor
Claire Lugassy
Jean-Paul Escande
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Application granted granted Critical
Publication of ATE113651T1 publication Critical patent/ATE113651T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0697Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698Skin equivalents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/09Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323Adult fibroblasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/30Coculture with; Conditioned medium produced by tumour cells

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88403371T 1987-12-31 1988-12-30 Rekonstituierte tumoren, herstellungsverfahren und zusammensetzung für ihre anwendung. ATE113651T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8718495A FR2625511B1 (fr) 1987-12-31 1987-12-31 Procede d'obtention in vitro de tissus reconstitues

Publications (1)

Publication Number Publication Date
ATE113651T1 true ATE113651T1 (de) 1994-11-15

Family

ID=9358536

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88403371T ATE113651T1 (de) 1987-12-31 1988-12-30 Rekonstituierte tumoren, herstellungsverfahren und zusammensetzung für ihre anwendung.

Country Status (6)

Country Link
EP (1) EP0328839B1 (de)
JP (1) JPH0272870A (de)
AT (1) ATE113651T1 (de)
DE (1) DE3852022D1 (de)
FR (1) FR2625511B1 (de)
PT (1) PT89357B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0499932A1 (de) * 1991-02-16 1992-08-26 W.R. Grace & Co.-Conn. Tumorzellmasse, die Tumorzellen und Normalzellen enthält, und ihre Herstellung
EP0975807B1 (de) * 1997-05-02 2006-09-27 Gen-Probe Incorporated Zwei-schritt hybridisierung und einfang von einem polynukleotid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6133593B2 (de) * 1978-12-26 1986-08-02 Massachusetts Inst Technology
FR2610006B1 (fr) * 1987-01-22 1990-03-30 Sanofi Sa Procede de reconstitution in vitro de tumeurs

Also Published As

Publication number Publication date
DE3852022D1 (de) 1994-12-08
FR2625511A1 (fr) 1989-07-07
PT89357B (pt) 1995-03-01
JPH0272870A (ja) 1990-03-13
FR2625511B1 (fr) 1990-05-18
EP0328839B1 (de) 1994-11-02
EP0328839A1 (de) 1989-08-23
PT89357A (pt) 1989-12-29

Similar Documents

Publication Publication Date Title
ES2147720T3 (es) Factor de celulas madre.
ATE221118T1 (de) Verwendung von stammzellenfaktor und löslichen interleukin-6-rezeptor zur vermehrung der hämatopoietischen vorläuferzellen
RO93650B (ro) Procedeu pentru obtinerea unei polipeptide umane fiziologic activa
DE3586619D1 (de) Haematologische zusammensetzungen als referenz fuer drei populationen von leukocyten, verfahren zu deren herstellung und deren verwendung in ganzbluttestverfahren.
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
PT892849E (pt) Metodo para utilizacao do gene obeso e seu produto genico para estimular o desenvolvimento hematopoietico
ATE199261T1 (de) Hybride immunglobuline
FI854604A0 (fi) Onkostatiini-A:n käyttö diagnostisessa menetelmässä
PT874645E (pt) Complexos metalicos contendo grupos perfluoroalquilo e sua utilizacao no diagnostico por rmn
DE3769327D1 (de) Bindemittel zur verwendung bei der papierherstellung.
ES8704546A1 (es) Metodo de produccion de una proteina con actividad procoagu-lante del tipo de factor viii:c humano
DE3884778D1 (de) Feine Polierzusammensetzung für Plaketten.
DE3887194D1 (de) Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung.
EP1135531A4 (de) Methoden zur introduktion heterologer zellen in fische
DE69021742D1 (de) Verfahren zum Nachweis von kleinzelligem Carzinom und die Verwendung von Sequenzen, die Acylpeptid-Hydrolase codieren, für diesen zweck.
PL326236A1 (en) Novel compounds - derivatives of sulphonylpyrimidine exhibiting anticarcinogenous effect and method of obtaining them
Brouty‐Boyé et al. Fetal myofibroblast‐like cells isolated from post‐radiation fibrosis in human breast cancer
ATE113651T1 (de) Rekonstituierte tumoren, herstellungsverfahren und zusammensetzung für ihre anwendung.
IT1095579B (it) Procedimento per la produzione di particelle di colorante idrosolubili,resistenti all'usura,che non impolverano e che sono solubili in acqua
Smith et al. A new creativity test.
DE3585049D1 (de) Monoklonale antikoerper.
ES8701772A1 (es) Procedimiento para preparar complejos organicos de platino
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
GB1474006A (en) Process for obtaining continuous lines of tumoral cells in vitro

Legal Events

Date Code Title Description
EEFA Change of the company name
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties